Zhejiang Ausun Pharmaceutical Co., Ltd. (SHA:603229)
China flag China · Delayed Price · Currency is CNY
9.60
-0.12 (-1.23%)
At close: Feb 13, 2026

SHA:603229 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
1,1291,0961,124608.85564.55739.11
Trading Asset Securities
6.32.24-4.02110-
Cash & Short-Term Investments
1,1351,0991,124612.87674.55739.11
Cash Growth
10.73%-2.29%83.44%-9.14%-8.73%116.06%
Accounts Receivable
209.8196.58132.75134.8166.2445.56
Other Receivables
2.911.632.828.491.490.84
Receivables
212.72198.21135.57143.367.7346.4
Inventory
424.36400.95365.18320.57243.44190.17
Other Current Assets
21.211.4849.7559.9734.864.25
Total Current Assets
1,7941,7091,6751,1371,021979.93
Property, Plant & Equipment
1,0361,0411,046950.94601.46299.92
Long-Term Investments
72.5672.5667.3750.1432.6413.08
Other Intangible Assets
152.28155.39150.37161.98164.277.3
Long-Term Deferred Tax Assets
1.260.46-6.874.474.72
Other Long-Term Assets
4.253.9912.718.6916.16.74
Total Assets
3,0602,9822,9522,3151,8391,382
Accounts Payable
264.59351.64410.85519.32402.25171.26
Accrued Expenses
26.8946.8740.1142.9131.6322.35
Short-Term Debt
330.97270.31300.26160.1265.0741.04
Current Portion of Long-Term Debt
---9.16--
Current Portion of Leases
1.041.040.87---
Current Income Taxes Payable
5.362.5310.21-5.811.74
Current Unearned Revenue
1.190.917.0612.6323.232.53
Other Current Liabilities
1.591.231.611.282.334.95
Total Current Liabilities
631.62674.53770.97745.42530.32243.87
Long-Term Debt
44.23--72.7444.86-
Long-Term Leases
0.41.082.04---
Long-Term Unearned Revenue
36.834.8934.9123.519.4610.94
Long-Term Deferred Tax Liabilities
--2.0712.51--
Total Liabilities
713.05710.5809.99854.19584.64254.81
Common Stock
830.3830.3593.07401.87287.05239.21
Additional Paid-In Capital
440.23440.23677.45394.72509.54557.38
Retained Earnings
1,1281,002871.92665.46459.36331.37
Comprehensive Income & Other
-0.81-0.83-0.86-0.91-1.14-1.08
Shareholders' Equity
2,3472,2722,1421,4611,2551,127
Total Liabilities & Equity
3,0602,9822,9522,3151,8391,382
Total Debt
376.63272.43303.17242.02109.9341.04
Net Cash (Debt)
758.8826.1821.06370.85564.62698.06
Net Cash Growth
5.05%0.61%121.40%-34.32%-19.12%134.94%
Net Cash Per Share
0.911.001.000.460.710.94
Filing Date Shares Outstanding
790.92828.3830.3787.66787.66787.66
Total Common Shares Outstanding
790.92830.3830.3787.66787.66787.66
Working Capital
1,1621,035903.76391.28490.26736.06
Book Value Per Share
2.972.742.581.861.591.43
Tangible Book Value
2,1952,1161,9911,2991,0911,050
Tangible Book Value Per Share
2.782.552.401.651.381.33
Buildings
-261.11224.84168.11150.71135.9
Machinery
-559.12510.1278.07223.16211.87
Construction In Progress
-495.66526.23685.01379.2477.04
Source: S&P Global Market Intelligence. Standard template. Financial Sources.